BFC Planning’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
BFC Planning's NVO Position: Q3 2026 in Review
BFC Planning reduced its Novo Nordisk (NVO) stake by 2.9% in Q3 2026, selling an estimated $14.7K and leaving 10,741 shares worth $407K. The position accounts for 0.02% of the portfolio, ranked #672.
BFC Planning first reported a position in NVO in Q3 2024 and has held it in 9 quarters since. The position peaked at $1.6M in Q4 2025. 1,061 funds tracked by Wall St. Rank hold NVO as of Q3 2026.
- BFC Planning held 10,741 shares of Novo Nordisk worth $407K as of Q3 2026.
- BFC Planning sold 319 Novo Nordisk shares in Q3 2026, an estimated $14.7K.
- Novo Nordisk made up 0.02% of BFC Planning's portfolio in Q3 2026, its #672 holding.
- BFC Planning first reported a position in Novo Nordisk in Q3 2024 and has held it in 9 quarters since.
- BFC Planning's Novo Nordisk position peaked at $1.6M in Q4 2025.
- 1,061 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.